Literature DB >> 10900159

Derivation of diabetes-resistant congenic lines from the nonobese diabetic mouse.

M McDuffie1.   

Abstract

Autoimmune diabetes is a polygenic disease process in man and rodents. To identify and characterize genes involved in the pathogenesis of diabetes in nonobese diabetic (NOD) mice, we initiated a repetitive backcross of diabetes-resistant C57L/J mice onto the NOD strain. This breeding scheme was based on the premise that selection for the trait of disease resistance among genetically mixed mice could be used to maintain transmission of nonpermissive alleles from the diabetes-resistant strain at critical diabetes susceptibility loci. Each of the three recombinant congenic mouse lines derived by this strategy retains a unique constellation of C57L/J-derived DNA segments. Consistent with the involvement of different genetic loci, the pancreatic histology of disease-resistant mice differs from that in NOD mice in a line-specific manner. Functional studies using these lines demonstrate that pathogenesis of autoimmune diabetes is a multistep process which can be blocked at a minimum of three critical, genetically determined points. Copyright 2000 Academic Press.

Entities:  

Mesh:

Year:  2000        PMID: 10900159     DOI: 10.1006/clim.2000.4893

Source DB:  PubMed          Journal:  Clin Immunol        ISSN: 1521-6616            Impact factor:   3.969


  13 in total

Review 1.  The immunogenetic architecture of autoimmune disease.

Authors:  An Goris; Adrian Liston
Journal:  Cold Spring Harb Perspect Biol       Date:  2012-03-01       Impact factor: 10.005

2.  A recombination hotspot leads to sequence variability within a novel gene (AK005651) and contributes to type 1 diabetes susceptibility.

Authors:  Iris K L Tan; Leanne Mackin; Nancy Wang; Anthony T Papenfuss; Colleen M Elso; Michelle P Ashton; Fiona Quirk; Belinda Phipson; Melanie Bahlo; Terence P Speed; Gordon K Smyth; Grant Morahan; Thomas C Brodnicki
Journal:  Genome Res       Date:  2010-11-04       Impact factor: 9.043

Review 3.  Nonobese diabetic mice and the genetics of diabetes susceptibility.

Authors:  Edward H Leiter
Journal:  Curr Diab Rep       Date:  2005-04       Impact factor: 4.810

4.  Nonobese diabetic mouse congenic analysis reveals chromosome 11 locus contributing to diabetes susceptibility, macrophage STAT5 dysfunction, and granulocyte-macrophage colony-stimulating factor overproduction.

Authors:  Sally A Litherland; Kristie M Grebe; Nicole S Belkin; Edward Paek; Jessica Elf; Mark Atkinson; Laurence Morel; Michael J Clare-Salzler; Marcia McDuffie
Journal:  J Immunol       Date:  2005-10-01       Impact factor: 5.422

5.  "Agouti NOD": identification of a CBA-derived Idd locus on Chromosome 7 and its use for chimera production with NOD embryonic stem cells.

Authors:  Jing Chen; Peter C Reifsnyder; Felix Scheuplein; William H Schott; Maria Mileikovsky; Sharon Soodeen-Karamath; Andras Nagy; Michael H Dosch; James Ellis; Friedrich Koch-Nolte; Edward H Leiter
Journal:  Mamm Genome       Date:  2005-10-29       Impact factor: 2.957

6.  Cutting edge: genetic characterization of IFN-producing killer dendritic cells.

Authors:  Fanny Guimont-Desrochers; Zachary John Cappello; Miguel Chagnon; Marcia McDuffie; Sylvie Lesage
Journal:  J Immunol       Date:  2009-05-01       Impact factor: 5.422

7.  T-bet-deficient NOD mice are protected from diabetes due to defects in both T cell and innate immune system function.

Authors:  Jonathan H Esensten; Michael R Lee; Laurie H Glimcher; Jeffrey A Bluestone
Journal:  J Immunol       Date:  2009-06-17       Impact factor: 5.422

8.  Nonobese diabetic (NOD) mice congenic for a targeted deletion of 12/15-lipoxygenase are protected from autoimmune diabetes.

Authors:  Marcia McDuffie; Nelly A Maybee; Susanna R Keller; Brian K Stevens; James C Garmey; Margaret A Morris; Elizabeth Kropf; Claudia Rival; Kaiwen Ma; Jeffrey D Carter; Sarah A Tersey; Craig S Nunemaker; Jerry L Nadler
Journal:  Diabetes       Date:  2007-10-16       Impact factor: 9.461

9.  GM-CSF induces STAT5 binding at epigenetic regulatory sites within the Csf2 promoter of non-obese diabetic (NOD) mouse myeloid cells.

Authors:  F Seydel; E Garrigan; B Stutevoss; N Belkin; B Makadia; J Carter; J-D Shi; A Davoodi-Semiromi; M McDuffie; S A Litherland
Journal:  J Autoimmun       Date:  2008-10-21       Impact factor: 7.094

10.  TCR transgenic mice reveal the impact of type 1 diabetes loci on early and late disease checkpoints.

Authors:  Erin E Hillhouse; Adrian Liston; Roxanne Collin; Eric Desautels; Christopher C Goodnow; Sylvie Lesage
Journal:  Immunol Cell Biol       Date:  2016-04-05       Impact factor: 5.126

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.